Descriptor: "CHILDREN" / Publisher: oxford university press / usa / Search Limiters: Full Text / Topic: adolescence and anxiety / Region: canada - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"CHILDREN"' showing total 3 results

Start Over Descriptor "CHILDREN" Search Limiters Full Text Topic adolescence Topic anxiety Region canada Publisher oxford university press / usa

Author: Klein, Benjamin, Rajendram, Rageen, Hrycko, Sophia, Poynter, Aven, Ortiz-Alvarez, Oliva, Saunders, Natasha, and Andrews, Debra
Subjects: *ANXIETY diagnosis, *SYMPTOMS, *ANXIETY, *CHILDREN, *ADOLESCENCE
Abstract: Anxiety disorders are the most common mental health concerns affecting Canadian children and adolescents. The Canadian Paediatric Society has developed two position statements that summarize current evidence regarding the diagnosis and management of anxiety disorders. Both statements offer evidence-informed guidance to support paediatric health care providers (HCPs) making decisions around the care of children and adolescents with these conditions. The objectives of Part 1, which focuses on assessment and diagnosis, are to: (1) review the epidemiology and clinical characteristics of anxiety disorders and (2) describe a process for assessment of anxiety disorders. Specific topics are reviewed, including prevalence, differential diagnosis, co-occurring conditions, and the process of assessment. Approaches are offered for standardized screening, history-taking, and observation. Associated features and indicators that distinguish anxiety disorders from developmentally appropriate fears, worries, and anxious feelings are considered. Note that when the word 'parent' (singular or plural) is used, it includes any primary caregiver and every configuration of family. [ABSTRACT FROM AUTHOR]
Published: 2023
Full Text: View/download PDF

Author: Korczak, Daphne J.
Subjects: *DETOXIFICATION (Substance abuse treatment), *PEDIATRICS, *MENTAL illness drug therapy, *ANXIETY, *DRUG monitoring, *FLUOXETINE, *EVALUATION of medical care, *MEDICAL protocols, *PATIENT compliance, *RISK assessment, *EVIDENCE-based medicine, *SEROTONIN uptake inhibitors, *PROFESSIONAL practice, *SUICIDAL ideation, *CITALOPRAM, *FLUVOXAMINE, *ADOLESCENCE, *CHILDREN, *SOCIETIES
Published: 2013

Author: Korczak, Daphne J.
Subjects: *DETOXIFICATION (Substance abuse treatment), *PEDIATRICS, *MENTAL illness drug therapy, *ANXIETY, *DRUG monitoring, *FLUOXETINE, *EVALUATION of medical care, *MEDICAL protocols, *PATIENT compliance, *RISK assessment, *EVIDENCE-based medicine, *SEROTONIN uptake inhibitors, *PROFESSIONAL practice, *SUICIDAL ideation, *CITALOPRAM, *FLUVOXAMINE, *ADOLESCENCE, *CHILDREN, *SOCIETIES
Abstract: Comprehensive clinical management plans for treating depression or anxiety disorders in children and adolescents frequently include the use of selective serotonin reuptake inhibitor (SSRI) medications. This statement reviews empirical data regarding the effectiveness of specific SSRI medications, monitoring guidelines, and potential adverse effects of SSRI use including risk of suicidality. SSRI medications can be effective in treating child and adolescent depression and anxiety disorders. Untreated depressive illness may be more harmful than appropriate use of SSRI medication. Physicians should ensure careful elicitation and documentation of baseline depressive and anxious symptoms before initiating SSRI medication. Following medication initiation, patients should also be closely monitored for potential adverse effects, including suicidal ideation and behaviour. [ABSTRACT FROM AUTHOR]
Published: 2013

Books, media, physical & digital resources

Searchworks